Behbahani Ali

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Behbahani Ali
CIK #0001613867
EDGAR Form CIK 2011 - 2026
3 [0001613867]
4 [0001613867]
5 [0001613867]
Form 3/4/5 Subject 2011 - 2026
Monte Rosa Therapeutics Inc
Behbahani Ali
Black Diamond Therapeutics Inc
Nkarta Inc
Korro Bio Inc
CRISPR Therapeutics AG
Arcellx Inc
Trevi Therapeutics Inc
SpyGlass Pharma Inc
NeueHealth Inc
Adaptimmune Therapeutics PLC
NEA Partners 16 LP
Baskett Forest
Chang Carmen
Walker Paul Edward
Sandell Scott D
New Enterprise Associates 16 LP
Florence Anthony A Jr
Makhzoumi Mohamad
Tapimmune Inc
NEA 16 GP LLC
MBX Biosciences Inc
CVRx Inc
Savara Inc
Mirum Pharmaceuticals Inc
Oyster Point Pharma Inc
Akouos Inc
Minerva Surgical Inc
Genocea Biosciences Inc
Metacrine Inc
Regulus Therapeutics Inc
X4 Pharmaceuticals Inc
Nevro Corp
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Black Diamond Therapeutics Inc BDTX
Common Stock
2026-03-20 Grant 6,919 $2.15 14,876
Korro Bio Inc KRRO
Common Stock
2026-03-10 Grant 207,100 $11.11 2,300,881
Korro Bio Inc KRRO
Pre-Funded Warrants · derivative
2026-03-10 Grant 242,945 $11.11 2,699,119
SpyGlass Pharma Inc SGP
Common Stock
2026-02-09 Conversion 737,962
SpyGlass Pharma Inc SGP
Common Stock
2026-02-09 Conversion 1,370,168
SpyGlass Pharma Inc SGP
Common Stock
2026-02-09 Conversion 1,370,168
SpyGlass Pharma Inc SGP
Common Stock
2026-02-09 Conversion 1,619,240
SpyGlass Pharma Inc SGP
Common Stock
2026-02-09 Conversion 954,990
SpyGlass Pharma Inc SGP
Series B Preferred Stock · derivative
2026-02-09 Conversion 1,619,240
SpyGlass Pharma Inc SGP
Common Stock
2026-02-09 Conversion 402,273
SpyGlass Pharma Inc SGP
Common Stock
2026-02-09 Buy 937,500 $16.00 15,000,000
SpyGlass Pharma Inc SGP
Series C-2 Preferred Stock · derivative
2026-02-09 Conversion 1,370,168
SpyGlass Pharma Inc SGP
Series C-1 Preferred Stock · derivative
2026-02-09 Conversion 1,370,168
SpyGlass Pharma Inc SGP
Series A Preferred Stock · derivative
2026-02-09 Conversion 954,990
SpyGlass Pharma Inc SGP
Series B Preferred Stock · derivative
2026-02-09 Conversion 402,273
SpyGlass Pharma Inc SGP
Series D Preferred Stock · derivative
2026-02-09 Conversion 737,962
SpyGlass Pharma Inc SGP
Stock Option (right to buy) · derivative
2026-02-05 Grant 27,400 $0.00
Black Diamond Therapeutics Inc BDTX
Common Stock
2025-12-12 Grant 5,208 $2.76 14,374
NeueHealth Inc NEUE
Warrant (Right to Buy) · derivative
2025-10-02 Option exercise 124,085 $0.00
NeueHealth Inc NEUE
Common Stock
2025-10-02 Sell 900 $6.75 6,075
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com